Seladelpar Drug Interactions
Currently displaying a list of 150 drugs known to interact with seladelpar.
- 4 major drug interactions
- 145 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with seladelpar
Note: Showing generic names only.
- abametapir topical
- acalabrutinib
- adagrasib
- alpelisib
- amiodarone
- amprenavir
- apalutamide
- aprepitant
- artesunate
- asciminib
- atazanavir
- capmatinib
- carbamazepine
- cenobamate
- ceritinib
- chloramphenicol
- cholestyramine
- ciprofloxacin
- clarithromycin
- clofazimine
- clopidogrel
- cobicistat
- colesevelam
- colestipol
- conivaptan
- crizotinib
- cyclosporine
- echinacea
- elacestrant
- eltrombopag
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- erythromycin
- ezogabine
- febuxostat
- fedratinib
- fenfluramine
- fenofibrate
- fenofibric acid
- fexinidazole
- fluconazole
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
- fostemsavir
- futibatinib
- lapatinib
- lasmiditan
- lazertinib
- lefamulin
- leflunomide
- lenacapavir
- leniolisib
- letermovir
- levoketoconazole
- lonafarnib
- lurasidone
- pacritinib
- palbociclib
- penicillin g benzathine
- penicillin g potassium
- penicillin g sodium
- phenobarbital
- phenytoin
- pirtobrutinib
- ponatinib
- posaconazole
- pralsetinib
- pretomanid
- primidone
- probenecid
- regorafenib
- resmetirom
- ribociclib
- rifampin
- rifapentine
- ripretinib
- ritlecitinib
- ritonavir
- rolapitant
- rucaparib
- tafamidis
- tedizolid
- telaprevir
- telithromycin
- tepotinib
- teriflunomide
- ticagrelor
- tivozanib
- tolvaptan
- troleandomycin
- tucatinib
Seladelpar disease interactions
There are 3 disease interactions with seladelpar which include:
Report options
More about seladelpar
- seladelpar consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Livdelzi
Livdelzi (seladelpar) is an oral prescription medicine that may be used to treat primary biliary ...
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Actigall
Actigall is used for gallbladder disease, primary biliary cholangitis
Ocaliva
Ocaliva may be used to treat primary biliary cholangitis (PBC) in adults without cirrhosis or with ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Urso Forte
Urso Forte is used for gallbladder disease, primary biliary cholangitis
Reltone
Reltone is used for gallbladder disease, primary biliary cholangitis
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Obeticholic acid
Obeticholic acid (brand name Ocaliva) may be used to treat primary biliary cholangitis (PBC) in ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
